Pro-Dex Q4 revenue down 16% YoY; full-year net income up 54% on record backlog $41.6M

PRO DEX INC

2024-Q1 EPS reported -$0.17 revenue$11,938,000

Q4 net sales fell 16% YoY to $10.6M; net income down $336K to $1.5M ($0.42 diluted EPS) vs $0.49 last year.
Full-year net sales up 10% to $46.0M; net income $7.1M ($1.95 diluted EPS) vs $4.6M ($1.21) last year, boosted by unrealized gain on Monogram warrant.
Record backlog of $41.6M as of June 30, 2023; new Franklin facility operational.
Medical device sales declined due to customer inventory buildup; repair revenue increased $6.0M for the year from enhanced repair program.
Executed new distribution agreement for thoracic driver in Q4; launched in Q1 FY2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PRO DEX INC reported financial results for the fourth fiscal quarter and fiscal year ended June 30, 2023.

Period: the fourth fiscal quarter and fiscal year ended June 30, 2023
Result: reported results

Exact text from the filing

Pro-Dex, Inc. (the "Company") is issuing a press release announcing its financial performance for the fourth fiscal quarter and fiscal year ended June 30, 2023.

View on SEC.gov

Browse all earnings releases →

PRO DEX INC filing history →

Source: SEC EDGAR

accession 0001079973-23-001431

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.